Loss of p53 Compensates for αv-Integrin Function in Retinal Neovascularization
Open Access
- 1 April 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (16) , 13371-13374
- https://doi.org/10.1074/jbc.c200044200
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrinsNature Medicine, 2002
- Extensive Vasculogenesis, Angiogenesis, and Organogenesis Precede Lethality in Mice Lacking All αv IntegrinsCell, 1998
- Cell adhesion and angiogenesisTrends in Cell Biology, 1996
- Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases.Proceedings of the National Academy of Sciences, 1996
- Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis.Journal of Clinical Investigation, 1996
- Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor–type integrins inhibits retinal neovascularizationNature Medicine, 1996
- Definition of Two Angiogenic Pathways by Distinct α v IntegrinsScience, 1995
- Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.Journal of Clinical Investigation, 1995
- Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vesselsCell, 1994
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994